Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kemox (Shandong Kemox Cellulose Co., Ltd.) is a leading manufacturer of cellulose ethers, specializing in the production of Hydroxypropyl Methylcellulose (HPMC), Hydroxyethyl Methylcellulose (HEMC), and Hydroxyethyl Cellulose (HEC). The company serves various industries, including construction, detergents, food, and pharmaceuticals. In the pharmaceutical sector, Kemox provides high-quality HPMC used as an excipient for tablet coatings, binders, and controlled-release formulations. Headquartered in Jinan, China, Kemox focuses on research, development, and large-scale production to meet global demand for cellulose-based additives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kemox Labs.